Arca Biopharma (ABIO) Announces Quarterly Results
Arca Biopharma (NASDAQ:ABIO) announced its earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.13) by $0.02, AmericanBankingNews.com reports.
Arca Biopharma (NASDAQ:ABIO) opened at 1.39 on Tuesday. Arca Biopharma has a 52-week low of $1.19 and a 52-week high of $2.54. The stock’s 50-day moving average is $1.43 and its 200-day moving average is $1.62. The company’s market cap is $29.2 million.
ARCA biopharma, Inc (NASDAQ:ABIO) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.